Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells
about
CRISPR/Cas9 and cancer targets: future possibilities and present challengesEpigenome engineering in cancer: fairytale or a realistic path to the clinic?Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatmentTALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cellsGenome editing and the next generation of antiviral therapy.The CRISPR/Cas9 genome editing methodology as a weapon against human virusesCRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC InfectionGene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies.CrisprGE: a central hub of CRISPR/Cas-based genome editing.Therapeutic gene editing: delivery and regulatory perspectivesType II CRISPR/Cas9 approach in the oncological therapy.ge-CRISPR - An integrated pipeline for the prediction and analysis of sgRNAs genome editing efficiency for CRISPR/Cas system.The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System.Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system.Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.Therapeutic vaccines for high-risk HPV-associated diseases.CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells.Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy
P2860
Q26769907-270BEAE8-1EA1-4539-BFC0-C14AC2895435Q26861350-50FF7833-111D-445D-913A-9DD29D80ECF3Q28087526-90A9226A-C03F-4E29-A170-2A5E76676EB7Q33905878-BBE0794B-327B-4B04-B509-4A35DFC24449Q34529971-009A9194-CE21-4117-8B0F-0123F80A7BF1Q35654689-F629249D-E1F1-4A4A-A883-C4326A3EFAB4Q35770584-8AA9285D-5A93-4737-90D9-F4A55B21F7EEQ36216276-3C240EF6-A3E9-4EF1-8968-C340EE70E867Q36494284-9D301F0B-A421-42E1-9EA8-F6C0DE5119E3Q37411994-C3E6C90F-6B77-463E-827A-4E5DBA3644DAQ37559174-E7E33075-E467-4BAF-8ED6-1DAAB93325A6Q38516454-6670565F-E8F9-46F9-9E7A-4B26D2EBC531Q38859113-1416E8E3-3987-4774-8B8C-AD2FF204EA72Q39230418-D8B88D5D-B589-4597-A70B-2D36B8BD0C20Q39376221-C5893970-36D8-448A-8F7F-5F02B3F445AEQ39434768-23B1D5E8-28BD-4DC5-B157-C70C82589076Q41035560-541360DD-15BD-42EE-BA7D-F357AC5DBBF2Q41930897-613A7B92-82FA-4521-A775-5E3446570357Q46208205-8AFF057C-0373-49EF-8F3A-F32473E18CE5Q47255618-70B185A8-48D1-46BC-A028-74CD6E311431Q47275614-8CC03387-6607-453F-B1CB-F50ADE2543C9Q57039753-AEFDE1A1-1797-4AF0-B919-B3B1A64D5D30
P2860
Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@ast
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@en
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@nl
type
label
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@ast
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@en
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@nl
prefLabel
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@ast
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@en
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@nl
P2093
P2860
P356
P1476
Disruption of HPV16-E7 by CRIS ...... ve human cervical cancer cells
@en
P2093
Changlin Zhang
Liming Wang
Wencheng Ding
P2860
P304
P356
10.1155/2014/612823
P407
P50
P577
2014-07-20T00:00:00Z